Mon, March 9, 2020
Sun, March 8, 2020
Fri, March 6, 2020
Thu, March 5, 2020

Matt Miksic Maintained (ABT) at Buy with Decreased Target to $94 on, Mar 6th, 2020

Matt Miksic of Credit Suisse, Maintained "Abbott Laboratories" (ABT) at Buy with Decreased Target from $104 to $94 on, Mar 6th, 2020.

Matt has made no other calls on ABT in the last 4 months.



There are 10 other peers that have a rating on ABT. Out of the 10 peers that are also analyzing ABT, 4 agree with Matt's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Amit Hazan of "Goldman Sachs" Initiated at Hold and Held Target at $96 on, Thursday, February 13th, 2020
  • Marie Thibault of "BTIG" Initiated at Hold on, Thursday, February 6th, 2020
  • Danielle Antalffy of "SVB Leerink" Maintained at Hold with Increased Target to $102 on, Thursday, January 23rd, 2020
  • Christopher Pasquale of "Guggenheim" Downgraded from Strong Buy to Hold on, Thursday, January 2nd, 2020


These are the ratings of the 6 analyists that currently disagree with Matt


  • Joanna Wiensch of "Citigroup" Initiated at Strong Buy and Held Target at $96 on, Thursday, March 5th, 2020
  • Matthew Taylor of "UBS" Maintained at Strong Buy with Increased Target to $105 on, Thursday, January 23rd, 2020
  • Rick Wise of "Stifel" Maintained at Strong Buy with Increased Target to $104 on, Thursday, January 23rd, 2020
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $103 on, Thursday, January 23rd, 2020
  • Jayson Bedford of "Raymond James" Maintained at Buy with Increased Target to $99 on, Thursday, January 23rd, 2020
  • David Lewis of "Morgan Stanley" Maintained at Buy with Increased Target to $101 on, Tuesday, December 17th, 2019